跳至主要内容
临床试验/NCT06440655
NCT06440655招募中不适用

A Randomized, Split-head Comparison Study of the Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients : A Pilot Study

Siriraj Hospital2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2023年5月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
2
主要终点
Trichoscan

研究概览

简要总结

The goal of this clinical trial is to compare between platelet-rich fibrin and platelet-rich plasma in female pattern hair loss . The main question[s] it aims to answer are:

  • efficacy between platelet-rich fibrin and platelet-rich plasma
  • safety between platelet-rich fibrin and platelet-rich plasma Participants will be divided into 2 side of treatment with composed of
  1. Platelet rich plasma
  2. Platelet rich fibrin

详细描述

Subject was treated both platelet-rich fibrin and platelet-rich plasma for 3 times which 1 month interval then will be followed up at 4 months and 6 months after last treatment

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Age 20-55 years
  • •Subject who was diagnosed with Female pattern hair loss in Ludwig Classification 2 (part width 2-4 centimeters) by Dermatologist

排除标准

  • •Pregnancy or Lactation subjects
  • •Subject with history of platelet dysfunction, low platelet, anemia, cirrhosis, cancer, or immunocompromised host
  • •Subject who are active smoking and alcoholism
  • •Subject who has dermatitis, scar or infection at intervention area
  • •Subject who has history of allergy to anesthesia drug
  • •Subject who taking NSAIDs, Hormonal drug, anticoagulants drug
  • •Subject who has psychiatric condition diagnosed by psychiatrist
  • •Subject who are not allowed to take a photo

研究组 & 干预措施

PRF and PRP

Experimental

All patients were treated with both platelet rich fibrin and platelet rich plasma but each side of head (left or right) was split with

  • one side of head was injected with platelet rich plasma at week 0,4 and 8 (total 3 times)
  • another side of head was injected with platelet rich fibrin at week 0,4 and 8 (total 3 times)

干预措施: Platelet rich fibrin (Device)

PRF and PRP

Experimental

All patients were treated with both platelet rich fibrin and platelet rich plasma but each side of head (left or right) was split with

  • one side of head was injected with platelet rich plasma at week 0,4 and 8 (total 3 times)
  • another side of head was injected with platelet rich fibrin at week 0,4 and 8 (total 3 times)

干预措施: Platelet rich plasma (Device)

结局指标

主要结局

Trichoscan

时间窗: baseline(week0), 4 months after last treatment(week20), 6 months after last treatment(week28)

Average counts and density of hair per 1.5mm\^2

次要结局

  • Visual analog scale(baseline(week0), 1 month after first treatment(week4), 1 months after second treatment(week8))
  • The 7-point of doctor subjective global assessment(baseline(week0),1 month after first treatment(week4), 1 months after second treatment(week8), 4 months after last treatment(week20), 6 months after last treatment(week28))
  • The 7-point of patient subjective global assessment(baseline(week0),1 month after first treatment(week4), 1 months after second treatment(week8), 4 months after last treatment(week20), 6 months after last treatment(week28))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rattapon Thuangtong

Associate Professor

Siriraj Hospital

研究点 (2)

Loading locations...

相似试验

The Efficacy and Safety of Platelet-rich Fibrin and... | 临床试验